{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:20:54Z","timestamp":1790601654243,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 Diabetes Mellitus (T2DM) involves patient-specific immune dysfunction not addressed by current diabetes management methods. Traditional methods to assess functional changes to PBMCs are too costly and time-intensive for routine use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied 57 individuals across healthy, prediabetic, and diabetic stages, performing chromatin imaging of live peripheral blood mononuclear cells (PBMCs) using a microfluidic imaging assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here, we present an orthogonal and adjunct chromatin imaging-based assay to monitor alterations to PBMCs during T2DM progression. By applying representation learning on chromatin images, we identified distinct PBMC clusters, with specific subpopulations enriched at different T2DM stages. We found that the levels of certain PBMC subsets are predictive of T2DM. Additionally, we observed significant changes in nuclear and chromatin mechanics in diabetic individuals compared to prediabetic and healthy individuals, along with decreased Lamin A\/C expression and increased cellular activation in diabetic PBMCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, this study demonstrated a cost-effective and scalable solution for the routine monitoring of T2DM using PBMC chromatin biomarkers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-026-01513-w","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:50:43Z","timestamp":1773773443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Detecting chromatin state alterations in PBMCs associated with Type 2 Diabetes Mellitus"],"prefix":"10.1038","volume":"6","author":[{"given":"Maryam Moazeni","family":"Afarani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajshikhar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7008-0216","authenticated-orcid":false,"given":"Caroline","family":"Uhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa","family":"Fetian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GV","family":"Shivashankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"1513_CR1","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41574-024-00973-1","volume":"20","author":"RA Ajjan","year":"2024","unstructured":"Ajjan, R. A. et al. Continuous glucose monitoring for the routine care of type 2 diabetes mellitus. Nat. Rev. Endocrinol. 20, 426\u2013440 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1513_CR2","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1177\/1932296820928100","volume":"15","author":"G Freckmann","year":"2021","unstructured":"Freckmann, G. et al. Insulin pump therapy for patients with type 2 diabetes mellitus: Evidence, current barriers, and new technologies. J. Diab. Sci. Technol. 15, 901\u2013915 (2021).","journal-title":"J. Diab. Sci. Technol."},{"key":"1513_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13098-025-01678-9","volume":"17","author":"Y Zhao","year":"2025","unstructured":"Zhao, Y. & Yue, R. White adipose tissue in type 2 diabetes and the effect of antidiabetic drugs. Diabetol. Metab. Syndr. 17, 116 (2025).","journal-title":"Diabetol. Metab. Syndr."},{"key":"1513_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-02069-y","volume":"29","author":"L Witcoski Junior","year":"2024","unstructured":"Witcoski Junior, L. et al. Metabolic reprogramming of macrophages in the context of type 2 diabetes. Eur. J. Med. Res. 29, 497 (2024).","journal-title":"Eur. J. Med. Res."},{"key":"1513_CR5","doi-asserted-by":"crossref","unstructured":"Giovenzana, A., Codazzi, V., Pandolfo, M. & Petrelli, A. T cell trafficking in human chronic inflammatory diseases. iScience 27, 110528 (2024).","DOI":"10.1016\/j.isci.2024.110528"},{"key":"1513_CR6","doi-asserted-by":"publisher","first-page":"e1002202","DOI":"10.1371\/journal.pbio.1002202","volume":"13","author":"R Haas","year":"2015","unstructured":"Haas, R. et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol. 13, e1002202 (2015).","journal-title":"PLoS Biol."},{"key":"1513_CR7","doi-asserted-by":"crossref","unstructured":"Macchi, C. et al. Monocarboxylate transporter 1 deficiency impacts CD8+ T lymphocytes proliferation and recruitment to adipose tissue during obesity. iScience 25, 104435 (2022).","DOI":"10.1016\/j.isci.2022.104435"},{"key":"1513_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41574-021-00575-1","volume":"18","author":"S SantaCruz-Calvo","year":"2022","unstructured":"SantaCruz-Calvo, S. et al. Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities. Nat. Rev. Endocrinol. 18, 23\u201342 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1513_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.immuni.2017.08.009","volume":"47","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil, G. S. Foundations of immunometabolism and implications for metabolic health and disease. Immunity 47, 406\u2013420 (2017).","journal-title":"Immunity"},{"key":"1513_CR10","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cmet.2022.07.002","volume":"34","author":"T H\u00e4ggl\u00f6f","year":"2022","unstructured":"H\u00e4ggl\u00f6f, T. et al. T-bet+ b cells accumulate in adipose tissue and exacerbate metabolic disorder during obesity. Cell Metab. 34, 1121\u20131136 (2022).","journal-title":"Cell Metab."},{"key":"1513_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41392-021-00805-y","volume":"6","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Natural killer cell-derived exosomal mir-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes. Signal Transduct. Target. Ther. 6, 409 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1513_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nm.2627","volume":"18","author":"O Osborn","year":"2012","unstructured":"Osborn, O. & Olefsky, J. M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18, 363\u2013374 (2012).","journal-title":"Nat. Med."},{"key":"1513_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath, M. Y. & Shoelson, S. E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98\u2013107 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"1513_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","volume":"18","author":"H Wang","year":"2021","unstructured":"Wang, H., Mehal, W., Nagy, L. E. & Rotman, Y. Immunological mechanisms and therapeutic targets of fatty liver diseases. Cell. Mol. Immunol. 18, 73\u201391 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"1513_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68347-1","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Zhao, S. -y, Wang, Y. -c, Xu, J. & Wang, J. The immune-inflammation factor is associated with diabetic nephropathy: evidence from NHANES 2013\u20132018 and geo database. Sci. Rep. 14, 17760 (2024).","journal-title":"Sci. Rep."},{"key":"1513_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41387-019-0103-z","volume":"9","author":"W He","year":"2019","unstructured":"He, W., Yuan, T. & Maedler, K. Macrophage-associated pro-inflammatory state in human islets from obese individuals. Nutr. Diab. 9, 36 (2019).","journal-title":"Nutr. Diab."},{"key":"1513_CR17","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41419-023-06146-8","volume":"14","author":"BC Sim","year":"2023","unstructured":"Sim, B. C. et al. Hepatic T-cell senescence and exhaustion are implicated in the progression of fatty liver disease in patients with type 2 diabetes and mouse model with nonalcoholic steatohepatitis. Cell Death Dis. 14, 618 (2023).","journal-title":"Cell Death Dis."},{"key":"1513_CR18","doi-asserted-by":"publisher","first-page":"e12711","DOI":"10.1111\/sji.12711","volume":"88","author":"V Sheikh","year":"2018","unstructured":"Sheikh, V. et al. Decreased regulatory function of CD4+ CD25+ CD45ra+ T cells and impaired il-2 signalling pathway in patients with type 2 diabetes mellitus. Scand. J. Immunol. 88, e12711 (2018).","journal-title":"Scand. J. Immunol."},{"key":"1513_CR19","doi-asserted-by":"crossref","unstructured":"Giovenzana, A. et al. Fat-to-blood recirculation of partially dysfunctional PD-1+ CD4 Tconv cells is associated with dysglycemia in human obesity. Iscience 27, 109032 (2024).","DOI":"10.1016\/j.isci.2024.109032"},{"key":"1513_CR20","doi-asserted-by":"publisher","first-page":"864","DOI":"10.4093\/dmj.2024.0140","volume":"48","author":"HT Nga","year":"2024","unstructured":"Nga, H. T., Nguyen, T. L. & Yi, H.-S. T-cell senescence in human metabolic diseases. Diab. Metab. J. 48, 864\u2013881 (2024).","journal-title":"Diab. Metab. J."},{"key":"1513_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41419-019-1494-4","volume":"10","author":"H-S Yi","year":"2019","unstructured":"Yi, H.-S. et al. T-cell senescence contributes to abnormal glucose homeostasis in humans and mice. Cell Death Dis. 10, 249 (2019).","journal-title":"Cell Death Dis."},{"key":"1513_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/cei.13344","volume":"197","author":"E Lau","year":"2019","unstructured":"Lau, E. et al. Type 2 diabetes is associated with the accumulation of senescent T cells. Clin. Exp. Immunol. 197, 205\u2013213 (2019).","journal-title":"Clin. Exp. Immunol."},{"key":"1513_CR23","doi-asserted-by":"publisher","first-page":"1397661","DOI":"10.3389\/fendo.2024.1397661","volume":"15","author":"D Gu","year":"2024","unstructured":"Gu, D. et al. Single-cell analysis of human pbmcs in healthy and type 2 diabetes populations: dysregulated immune networks in type 2 diabetes unveiled through single-cell profiling. Front. Endocrinol. 15, 1397661 (2024).","journal-title":"Front. Endocrinol."},{"key":"1513_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71946-3","volume":"10","author":"I Nojima","year":"2020","unstructured":"Nojima, I. et al. Dysfunction of CD8+ PD-1+ T cells in type 2 diabetes caused by the impairment of metabolism-immune axis. Sci. Rep. 10, 14928 (2020).","journal-title":"Sci. Rep."},{"key":"1513_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/cei.13187","volume":"194","author":"H Nam","year":"2018","unstructured":"Nam, H. et al. Functional status of immune cells in patients with long-lasting type 2 diabetes mellitus. Clin. Exp. Immunol. 194, 125\u2013136 (2018).","journal-title":"Clin. Exp. Immunol."},{"key":"1513_CR26","doi-asserted-by":"publisher","first-page":"1018608","DOI":"10.3389\/fendo.2022.1018608","volume":"13","author":"J Jin","year":"2023","unstructured":"Jin, J. et al. Depiction of immune heterogeneity of peripheral blood from patients with type ii diabetic nephropathy based on mass cytometry. Front. Endocrinol. 13, 1018608 (2023).","journal-title":"Front. Endocrinol."},{"key":"1513_CR27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41574-021-00512-2","volume":"17","author":"S Bellary","year":"2021","unstructured":"Bellary, S., Kyrou, I., Brown, J. E. & Bailey, C. J. Type 2 diabetes mellitus in older adults: clinical considerations and management. Nat. Rev. Endocrinol. 17, 534\u2013548 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1513_CR28","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3389\/fimmu.2020.01582","volume":"11","author":"G Daryabor","year":"2020","unstructured":"Daryabor, G., Atashzar, M. R., Kabelitz, D., Meri, S. & Kalantar, K. The effects of type 2 diabetes mellitus on organ metabolism and the immune system. Front. Immunol. 11, 1582 (2020).","journal-title":"Front. Immunol."},{"key":"1513_CR29","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3390\/life12081205","volume":"12","author":"K Kupai","year":"2022","unstructured":"Kupai, K. et al. Recent progress in the diagnosis and management of type 2 diabetes mellitus in the era of COVID-19 and single cell multi-omics technologies. Life 12, 1205 (2022).","journal-title":"Life"},{"key":"1513_CR30","doi-asserted-by":"publisher","first-page":"107758","DOI":"10.1016\/j.jdiacomp.2020.107758","volume":"35","author":"M Al Dubayee","year":"2021","unstructured":"Al Dubayee, M. et al. Metformin alters peripheral blood mononuclear cells (pbmc) senescence biomarkers gene expression in type 2 diabetic patients. J. Diab. Complications 35, 107758 (2021).","journal-title":"J. Diab. Complications"},{"key":"1513_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrendo.2016.87","volume":"12","author":"R Barr\u00e8s","year":"2016","unstructured":"Barr\u00e8s, R. & Zierath, J. R. The role of diet and exercise in the transgenerational epigenetic landscape of T2DM. Nat. Rev. Endocrinol. 12, 441\u2013451 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1513_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19365-w","volume":"11","author":"I Mandric","year":"2020","unstructured":"Mandric, I. et al. Optimized design of single-cell rna sequencing experiments for cell-type-specific eqtl analysis. Nat. Commun. 11, 5504 (2020).","journal-title":"Nat. Commun."},{"key":"1513_CR33","doi-asserted-by":"crossref","unstructured":"Santos Gonzalez, F. et al. A micro-costing study of mass-spectrometry based quantitative proteomics testing applied to the diagnostic pipeline of mitochondrial and other rare disorders. Orphanet J. Rare Dis. 19, 443 (2024).","DOI":"10.1186\/s13023-024-03462-w"},{"key":"1513_CR34","doi-asserted-by":"crossref","unstructured":"Challa, K. et al. Imaging and AI-based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies. npj Precis. Oncol. 7, 118 (2023).","DOI":"10.1038\/s41698-023-00484-8"},{"key":"1513_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50285-1","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Unsupervised representation learning of chromatin images identifies changes in cell state and tissue organization in dcis. Nat. Commun. 15, 6112 (2024).","journal-title":"Nat. Commun."},{"key":"1513_CR36","doi-asserted-by":"crossref","unstructured":"Helmut, S. et al. Controlled co-evaporation of silanes for nanoimprint stamps. Nanotechnology 16, S171\u2013S175 (2005).","DOI":"10.1088\/0957-4484\/16\/5\/007"},{"key":"1513_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35233-1","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang, X., Wang, X., Shivashankar, G. & Uhler, C. Graph-based autoencoder integrates spatial transcriptomics with chromatin images and identifies joint biomarkers for alzheimer\u2019s disease. Nat. Commun. 13, 7480 (2022).","journal-title":"Nat. Commun."},{"key":"1513_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20249-2","volume":"12","author":"KD Yang","year":"2021","unstructured":"Yang, K. D. et al. Multi-domain translation between single-cell imaging and sequencing data using autoencoders. Nat. Commun. 12, 31 (2021).","journal-title":"Nat. Commun."},{"key":"1513_CR39","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1091\/mbc.E19-08-0420","volume":"31","author":"S Venkatachalapathy","year":"2020","unstructured":"Venkatachalapathy, S., Jokhun, D. S. & Shivashankar, G. Multivariate analysis reveals activation-primed fibroblast geometric states in engineered 3d tumor microenvironments. Mol. Biol. Cell 31, 803\u2013812 (2020).","journal-title":"Mol. Biol. Cell"},{"key":"1513_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/A:1023949509487","volume":"52","author":"S Monti","year":"2003","unstructured":"Monti, S., Tamayo, P., Mesirov, J. & Golub, T. Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach. Learn. 52, 91\u2013118 (2003).","journal-title":"Mach. Learn."},{"key":"1513_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-41695-z","volume":"9","author":"VA Traag","year":"2019","unstructured":"Traag, V. A., Waltman, L. & Van Eck, N. J. From louvain to leiden: guaranteeing well-connected communities. Sci. Rep. 9, 1\u201312 (2019).","journal-title":"Sci. Rep."},{"key":"1513_CR42","unstructured":"Van Rossum, G. & Drake, F. L. Python 3 Reference Manual (CreateSpace, Scotts Valley, CA, 2009)."},{"key":"1513_CR43","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: Machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"1513_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter, J. D. Matplotlib: a 2d graphics environment. Comput. Sci. Eng. 9, 90\u201395 (2007).","journal-title":"Comput. Sci. Eng."},{"key":"1513_CR45","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"ML Waskom","year":"2021","unstructured":"Waskom, M. L. Seaborn: statistical data visualization. J. Open Source Softw. 6, 3021 (2021).","journal-title":"J. Open Source Softw."},{"key":"1513_CR46","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s00125-023-05891-x","volume":"66","author":"A Kautzky-Willer","year":"2023","unstructured":"Kautzky-Willer, A., Leutner, M. & Harreiter, J. Sex differences in type 2 diabetes. Diabetologia 66, 986\u20131002 (2023).","journal-title":"Diabetologia"},{"key":"1513_CR47","doi-asserted-by":"crossref","unstructured":"Gupta, S. et al. Developmental heterogeneity in DNA packaging patterns influences T-cell activation and transmigration. PLOS ONE 7, e43718 (2012).","DOI":"10.1371\/journal.pone.0043718"},{"key":"1513_CR48","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1101\/gad.346312.120","volume":"35","author":"YS Lee","year":"2021","unstructured":"Lee, Y. S. & Olefsky, J. Chronic tissue inflammation and metabolic disease. Genes Dev. 35, 307\u2013328 (2021).","journal-title":"Genes Dev."},{"key":"1513_CR49","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1073\/pnas.0803623105","volume":"105","author":"LM Villeneuve","year":"2008","unstructured":"Villeneuve, L. M. et al. Epigenetic histone h3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc. Natl. Acad. Sci. USA 105, 9047\u20139052 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1513_CR50","doi-asserted-by":"publisher","first-page":"13854","DOI":"10.1074\/jbc.M609446200","volume":"282","author":"F Miao","year":"2007","unstructured":"Miao, F. et al. Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes. J. Biol. Chem. 282, 13854\u201313863 (2007).","journal-title":"J. Biol. Chem."},{"key":"1513_CR51","first-page":"e143289","volume":"6","author":"MA Reddy","year":"2021","unstructured":"Reddy, M. A. et al. IncRNA DRAIR is downregulated in diabetic monocytes and modulates the inflammatory phenotype via epigenetic mechanisms. JCI Insight 6, e143289 (2021).","journal-title":"JCI Insight"},{"key":"1513_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02195-1","volume":"23","author":"MC Vinci","year":"2024","unstructured":"Vinci, M. C. et al. Persistent epigenetic signals propel a senescence-associated secretory phenotype and trained innate immunity in CD34+ hematopoietic stem cells from diabetic patients. Cardiovasc. Diabetol. 23, 107 (2024).","journal-title":"Cardiovasc. Diabetol."},{"key":"1513_CR53","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.bpj.2017.06.015","volume":"113","author":"H-Y Chang","year":"2017","unstructured":"Chang, H.-Y., Li, X. & Karniadakis, G. E. Modeling of biomechanics and biorheology of red blood cells in type 2 diabetes mellitus. Biophys. J. 113, 481\u2013490 (2017).","journal-title":"Biophys. J."},{"key":"1513_CR54","doi-asserted-by":"publisher","first-page":"C1263","DOI":"10.1152\/ajpcell.00273.2024","volume":"327","author":"G Romanelli","year":"2024","unstructured":"Romanelli, G., Villarreal, L., Espasand\u00edn, C. & Benech, J. C. Diabetes induces modifications in costameric proteins and increases cardiomyocyte stiffness. Am. J. Physiol. Cell Physiol. 327, C1263\u2013C1273 (2024).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1513_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11892-022-01453-4","volume":"22","author":"M Ortiz-Mart\u00ednez","year":"2022","unstructured":"Ortiz-Mart\u00ednez, M. et al. Recent developments in biomarkers for diagnosis and screening of type 2 diabetes mellitus. Curr. Diab. Rep. 22, 95\u2013115 (2022).","journal-title":"Curr. Diab. Rep."},{"key":"1513_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-017-0189-z","volume":"17","author":"C Phosat","year":"2017","unstructured":"Phosat, C. et al. Elevated c-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural Thais: a cross-sectional study. BMC Endocr. Disord. 17, 1\u20138 (2017).","journal-title":"BMC Endocr. Disord."},{"key":"1513_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-12-79","volume":"12","author":"ID Hjellestad","year":"2013","unstructured":"Hjellestad, I. D., Astor, M. C., Nilsen, R. M., S\u00f8fteland, E. & Jonung, T. HbA1c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients. Cardiovasc. Diabetol. 12, 79 (2013).","journal-title":"Cardiovasc. Diabetol."},{"key":"1513_CR58","doi-asserted-by":"publisher","first-page":"e020665","DOI":"10.1136\/bmjopen-2017-020665","volume":"8","author":"G Li","year":"2018","unstructured":"Li, G. et al. Evaluation of ADA HbA1c criteria in the diagnosis of pre-diabetes and diabetes in a population of Chinese adolescents and young adults at high risk for diabetes: a cross-sectional study. BMJ Open 8, e020665 (2018).","journal-title":"BMJ Open"},{"key":"1513_CR59","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1464-5491.2007.02106.x","volume":"24","author":"C Bennett","year":"2007","unstructured":"Bennett, C., Guo, M. & Dharmage, S. HbA1c as a screening tool for detection of type 2 diabetes: a systematic review. Diabet. Med. 24, 333\u2013343 (2007).","journal-title":"Diabet. Med."},{"key":"1513_CR60","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/jama.286.3.327","volume":"286","author":"AD Pradhan","year":"2001","unstructured":"Pradhan, A. D., Manson, J. E., Rifai, N., Buring, J. E. & Ridker, P. M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327\u2013334 (2001).","journal-title":"JAMA"},{"key":"1513_CR61","doi-asserted-by":"crossref","unstructured":"Meigs, J. B. Multiple biomarker prediction of type 2 diabetes. Diabetes Care, 32, 1346\u20131348 (2009).","DOI":"10.2337\/dc09-0754"},{"key":"1513_CR62","first-page":"00120","volume":"5","author":"S Gupta","year":"2017","unstructured":"Gupta, S., Jain, U., Chauhan, N. et al. Laboratory diagnosis of HbA1c: a review. J. Nanomed. Res. 5, 00120 (2017).","journal-title":"J. Nanomed. Res."},{"key":"1513_CR63","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12325-015-0180-x","volume":"32","author":"R Hunter","year":"2015","unstructured":"Hunter, R. Cost-effectiveness of point-of-care C-reactive protein tests for respiratory tract infection in primary care in England. Adv. Ther. 32, 69\u201385 (2015).","journal-title":"Adv. Ther."},{"key":"1513_CR64","unstructured":"\u201cTesting for Diabetes Cost, Price of Lab Tests.\u201d FindLabTest.com, https:\/\/www.findlabtest.com\/lab-test\/testing-for-diabetes\/. Accessed 12 Mar. 2026."},{"key":"1513_CR65","unstructured":"https:\/\/www.ufluidix.com\/pricing\/. Ufluidix pricing information (2025). https:\/\/www.ufluidix.com\/pricing\/. Accessed 4 September 2025."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01513-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01513-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01513-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:03:06Z","timestamp":1778050986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01513-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1513"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01513-w","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"5 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"268"}}